Difficult-to-treat depression (also known as treatment-resistant depression) affects 20–50% of people with depression. It causes profound distress, contributes to long-term disability, and places a heavy burden on individuals, services, and society.
Despite a growing evidence base across medication, psychological therapies, and neuromodulation (e.g. TMS, tDCS), many people still receive limited support, especially in primary care. Access to specialist services is patchy. Long-term symptoms are common. Recovery remains elusive for many.
System-level barriers, including service fragmentation, limited specialist provision, and stigma, prevent timely and effective treatment.
So what can be done?
This free one-hour webinar cuts through the noise and brings you up to date on the latest evidence for managing difficult-to-treat depression.
Hosted by The Mental Elf, and designed for clinicians, prescribers, practitioners, and policymakers, this practical, evidence-focused session will:
- Summarise the most promising treatment options
- Highlight gaps in care and access across the UK
- Explore new approaches, from psychedelics to neuromodulation
- Offer clear recommendations for policy and practice
Don’t miss this chance to refresh your knowledge, reflect on your practice, and reimagine what good care could look like.
Organisers and speakers
- Prof Anthony Cleare, King's College London
- Prof Michael Browning, University of Oxford
- Dr Rupert McShane, University of Oxford
- Dr James Rucker, King's College London
- Dr Viktoriya Nikolova, King's College London
- TBC
